Zymeworks

ZYME67

$15.38arrow_drop_down5.35%-$0.87

ZYME67

$15.38

arrow_drop_down5.35%-$0.87

Performance History

Key Stats
Open	$17.23
Prev. Close	$17.21
EPS	-1.49
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	15.15	17.40
52 Week Range	6.12	17.67

Ratios







EPS	-1.49

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Zymeworks (ZYME)

Zymeworks Inc. (ZYME) is a biopharmaceutical company that specializes in the discovery, development, and commercialization of multifunctional protein-based therapeutics. The company's technology platform, known as Azymetric™, enables the design and engineering of novel antibody-based drugs with enhanced properties and improved therapeutic potential. Zymeworks applies its platform to develop proprietary product candidates targeting a wide range of diseases, including cancer, autoimmune disorders, and inflammatory diseases.

As of [insert date], Zymeworks Inc.'s stock price history has shown a steady upward trend. The stock has been performing well and has experienced significant growth over the past few years. Investors have been attracted to Zymeworks' innovative approach to drug development and the potential for its products to address unmet medical needs. With a market cap of [insert market cap], Zymeworks is considered a mid-cap company in the biopharmaceutical industry.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Kenneth H. Galbraith C.A.
Headquarters: Vancouver
Employees: 237
Exchange: NASDAQ

Keep an eye on Zymeworks

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Zymeworks 's (ZYME) price per share?

The current price per share for Zymeworks (ZYME) is $15.38. The stock has seen a price change of -$0.87 recently, indicating a -5.35% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Zymeworks (ZYME)?

For Zymeworks (ZYME), the 52-week high is $17.67, which is 14.85% from the current price. The 52-week low is $6.12, the current price is 151.39% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Zymeworks (ZYME) a growth stock?

Zymeworks (ZYME) has shown an average price growth of -4.94% over the past three years. It has received a score of 71 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Zymeworks as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Zymeworks (ZYME) stock price performance year to date (YTD)?

As of the latest data, Zymeworks (ZYME) has a year-to-date price change of 48.22%. Over the past month, the stock has experienced a price change of 15.68%. Over the last three months, the change has been 51.73%. Over the past six months, the figure is 70.94%. Looking at a longer horizon, the five-year price change stands at -57.24%.

help

Is Zymeworks (ZYME) a profitable company?

Zymeworks (ZYME) has a net income of -$118.67M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -213.78% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $76.01M, although specific revenue growth data is currently not available. Operating income is noted at -$138.05M. Furthermore, the EBITDA is -$114.71M.

help

What is the market capitalization of Zymeworks (ZYME)?

Zymeworks (ZYME) has a market capitalization of $1.06B. The average daily trading volume is 15.45, indicating the stock's liquidity and investor engagement.